Voroni develops novel TPD (Target Protein degraders) and kinase inhibitors with the aim to treat intractable and rare diseases. We are developing competitive therapies based on deep understanding of diseases and innovative technologies.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.